ScienceDex / Researcher record
Ferrer-Alegre, Marc
- National Center for Advancing Translational Sciences (no department on record)
From the FY2017 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 10% Funded
- Early Career
NIH Funding · FY2017
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $2,647,554 | 21 | #1,665 |
| 2018 | $7,667,505 | 18 | #230 |
| 2019 | $6,638,719 | 4 | #394 |
| 2021 | $5,025,316 | 7 | #692 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2017 · selected21 records
- FY201818 records
- FY20194 records
- FY20217 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2017 award records by amount
NIH award records listing Ferrer-Alegre, Marc as a PI. Multi-PI records show the full award amount for context.
- 1ZIATR000268-02ZIAContact PI3D Bioprinting of human native-like tissues as disease-in-a-dish models for drug discovery$1.6Maward amount
- 1ZIATR000243-03ZIAContact PITargeting Tumor-derived exRNA-Containing microvesicles by high throughput screening$180Kaward amount
- 1ZIATR000081-03ZIAContact PIIdentification of GPR32 agonists as potential anti-inflammatory agents$44.7Kaward amount
- 1ZIATR000083-03ZIAContact PIIdentification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction$44.7Kaward amount
- 1ZIATR000084-03ZIAContact PIIdentification of compounds that inhibit the interaction between IQGAP1 and Cdc42 and Rac1 for the treatment of cancer$44.7Kaward amount
- 1ZIATR000085-03ZIAContact PIIdentification of small molecule inhibitors of Neutral Sphingomyelinase 2 (nSMase2) as a new therapeutic approach for the treatment of neurodegenerative disorders$44.7Kaward amount
- 1ZIATR000086-03ZIAContact PIIdentification of novel agonist of the Relaxin family peptide receptor 2 (RXFP2) as potential new therapeutics for testicular maldescent$44.7Kaward amount
- 1ZIATR000088-03ZIAContact PIAdaptation of an Organotypic 3 Dimensional Culture for High-Throughput Screening$44.7Kaward amount
- 1ZIATR000096-03ZIAContact PIPAC1 receptor antagonists as potential treatments for depression and atherosclerosis associated with chronic stress$44.7Kaward amount
- 1ZIATR000097-03ZIAContact PIDevelopment of a novel pharmacologic strategy to activate normal pathways of differentiation in melanoma$44.7Kaward amount
+11 more grants not shown.
Award organization
Organizations that administered FY2017 awards listing Ferrer-Alegre, Marc as a PI.
FY2017 award administered by National Center for Advancing Translational Sciences ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardNational Center for Advancing Translational Sciences
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017$2M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #1665
- 2017Entered Top 25% NationallyRanked #1665
- 2017Entered Top 10% NationallyRanked #1665
- 2018$5M Cumulative Funding
- 2018$10M Cumulative Funding
- 2018Entered Top 5% NationallyRanked #230